Using a two-stage discounted cash flow model, analysts estimate Stryker’s intrinsic value at around $318 per share. This ...

Treace Medical Concepts' slower growth, losses, and competition raise investment risks despite innovative tech. Read more ...

Stryker (NYSE:SYK) announced that it will report financial results for its first quarter of fiscal year 2025 on Thursday, May 1, 2025. A press release will be issued at approximately 4:05 p.m. ET and ...